ZIMMER BIOMET HOLDINGS, INC. (NYSE:ZBH) Files An 8-K Other Events
Item8.01
| OTHER EVENTS |
Zimmer Biomet Holdings, Inc. issued a press release on June 13,
2017 announcing the resolution of the FDA Warning Letter related
to its Zhejiang, China manufacturing facility. A copy of the
press release is attached hereto as Exhibit 99.1 and the
information set forth therein is incorporated herein by reference
and constitutes a part of this report.
| Item9.01 | FINANCIAL STATEMENTS AND EXHIBITS |
| (d) | Exhibits |
|
Exhibit No. |
Description |
|
| 99.1 | Press Release, dated June 13, 2017, issued by the Registrant |
About ZIMMER BIOMET HOLDINGS, INC. (NYSE:ZBH)
Zimmer Biomet Holdings, Inc., formerly Zimmer Holdings, Inc., is engaged designing, manufacturing and marketing orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company’s products and solutions helps treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consists of the United States and includes other North, Central and South American markets; EMEA, consists of Europe and includes the Middle East and African markets, and Asia Pacific, consists of Japan and includes other Asian and Pacific markets. Its four product category segments include Americas Spine, Bone Healing Craniomaxillofacial and Thoracic, and Dental.